FDA's views on Digital Twins and Chatbots

Whether you're involved in research, as a site, sponsor, or CRO, be aware that the FDA is exploring technologies like digital twins and conversational chatbots. As you deploy AI in these fields, stay vigilant and consider the associated risks. The FDA has shifted towards a risk-based analysis, so it's crucial to assess and address the most important and common risks. Stay tuned for further discussions on this evolving topic. #darshantalks #kulkarnilawfirm #ai #fda #chatbots Website: http://www.darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshankulkarni/ Google Podcasts: https://podcasts.google.com/?feed=aHR0cHM6Ly93d3cuZGFyc2hhbmt1bGthcm5pLmNvbS9mZWVkL3BvZGNhc3Qv Apple Podcasts: https://podcasts.apple.com/us/podcast/darshantalks/id1465775909 iHeart Radio: https://www.iheart.com/podcast/269-darshantalks-51013132/ Sign up for my newsletter: http://recentrecap.darshankulkarni.com/ ---- Disclaimers: This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice or medical advice. Listening to this video or otherwise depending on discussions in this video do not, in any way, create an attorney attorney-client relationship